Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 284-291 , August 2010

Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: A rare case with human androgen-receptor gene analysis

  • Jen-Wei Tsai, MD

      Affiliations

    • Department of Anatomic Pathology, E-Da Hospital, Kaohsiung County, Taiwan
  • ,
  • Jen-Hui Tsou, MS

      Affiliations

    • Institute of Biosignal Transduction, College of Bioscience and Biotechnology, Tainan, Taiwan
  • ,
  • Liang-Yi Hung, PhD

      Affiliations

    • Institute of Biosignal Transduction, College of Bioscience and Biotechnology, Tainan, Taiwan
  • ,
  • Hung-Bo Wu, MD

      Affiliations

    • Division of Hematology-Oncology, Department of Internal Medicine, E-Da Hospital, Kaohsiung County, Taiwan
  • ,
  • Kung-Chao Chang, MD

      Affiliations

    • Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • Corresponding Author InformationReprint requests: Kung-Chao Chang, MD, Department of Pathology, National Cheng Kung University Hospital, 138 Sheng-Li Road, Tainan 704, Taiwan.

References 

  1. Chester W. Über Lipoidgranulomatose. Virchows Arch Pathol Anat. 1930;279:561–602
  2. Gaucher's disease and certain other inborn metabolic disorders: lipid (cholesterol) granulomatosis. In:  Jaffe HL editors. Metabolic, degenerative and inflammatory disease of bone and joints. Philadelphia: Lea & Febiger; 1972;p. 535–541
  3. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, Wechsler J, Brun B, Remy M, et al. Erdheim-Chester disease: clinical and radiologic characteristics of 59 cases. Medicine (Baltimore). 1996;75:157–169
  4. Egan AJ, Boardman LA, Tazelaar HD, Swensen SJ, Jett JR, Yousem SA, et al. Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol. 1999;23:17–26
  5. Zelger B, Rapini RP, Burgdorf W, Burg G. Langerhans cell histiocytosis. In:  LeBoit PE,  Burg G,  Weedon D,  Sarasain A editor. World Health Organization classification of tumors. Pathology and genetics of skin tumors. Lyon: International Agency for Research on Cancer (IARC) Press; 2006;p. 217–219
  6. Stockschlaeder M, Sucker C. Adult Langerhans cell histiocytosis. Eur J Haematol. 2006;76:363–368
  7. De Young BR, Unni KK. Langerhans cell histiocytosis. In:  Fletcher CDM,  Unni KK,  Mertens F editor. World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: International Agency for Research on Cancer (IARC) Press; 2002;p. 345–346
  8. In:  Swerdlow SH,  Campo E,  Harris NL,  Jaffe ES,  Pileri SA,  Stein H, et al. editor. World Health Organization classification of tumors of hematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer (IARC) Press; 2008;
  9. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, et al. Langerhans'-cell histiocytosis (histiocytosis X)–a clonal proliferative disease. N Engl J Med. 1994;331:154–160
  10. Yu RC, Chu C, Buluwela L, Chu AC. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Lancet. 1994;343:767–768
  11. Christie LJ, Evans AT, Bray SE, Smith ME, Kernohan NM, Levison DA, et al. Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon?. Hum Pathol. 2006;37:32–39
  12. Al-Quran S, Reith J, Bradley J, Rimsza L. Erdheim-Chester disease: case report, PCR-based analysis of clonality, and review of literature. Mod Pathol. 2002;15:666–672
  13. Chetritt J, Paradis V, Dargere D, Adle-Biassette H, Maurage CA, Mussini JM, et al. Chester-Erdheim disease: a neoplastic disorder. Hum Pathol. 1999;30:1093–1096
  14. Dickson BC, Pethe V, Chung CT-S, Howarth DJC, Bilbao JM, Fornasier VL, et al. Systemic Erdheim-Chester disease. Virchows Arch. 2008;452:221–227
  15. Uchida T, Ohashi H, Aoki E, Nakahara Y, Hotta T, Murate T, et al. Clonality analysis by methylation-specific PCR for the human androgen-receptor gene (HUMARA-MSP). Leukemia. 2000;14:207–212
  16. Chi DH, Sung KJ, Koh JK. Eruptive xanthoma-like cutaneous Langerhans cell histiocytosis in an adult. J Am Acad Dermatol. 1996;34:688–689
  17. Knobler RM, Neumann RA, Gebhart W, Radaskiewicz T, Ferenci P, Widhalm K. Xanthoma disseminatum with progressive involvement of the central nervous and hepatobiliary systems. J Am Acad Dermatol. 1990;23:341–346
  18. Mills JA, Gonzalez RG, Jaffe R. Case records of the Massachusetts General Hospital, case 25-2008: a 43-year-old man with fatigue and lesions in the pituitary and cerebellum. N Engl J Med. 2008;359:736–747
  19. Walker PD, Rosai J, Dorfman RF. The osseous manifestations of sinus histiocytosis with massive lymphadenopathy. Am J Clin Pathol. 1981;75:131–139
  20. Zimran A, Kay A, Gelbart T, Garver P, Thurston D, Saven A, et al. Gaucher disease: clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine (Baltimore). 1992;71:337–353
  21. Lahey ME. Histiocytosis X–comparison of three treatment regimens. J Pediatr. 1975;87:179–183
  22. Lucaya J. Histiocytosis X. Am J Dis Child. 1971;121:289–295
  23. Granier M, Micheau A, Serre I. A rare cause of cardiac tumor: an Erdheim-Chester disease with cardiac involvement co-existing with an intracerebral Langerhans cell histiocytosis. Eur Heart J. 2008;29:1929
  24. Case records of the Massachusetts General Hospital, weekly clinicopathological exercises, case 9-2000: a 41-year-old man with multiple bony lesions and adjacent soft-tissue masses. N Engl J Med. 2000;342:875–883
  25. Brower AC, Worsham GF, Dudley AH. Erdheim-Chester disease: a distinct lipoidosis or part of the spectrum of histiocytosis?. Radiology. 1984;151:35–38
  26. Kambouchner M, Colby TV, Domenge C, Battesti JP, Soler P, Tazi A. Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone. Histopathology. 1997;30:353–358
  27. Bisceglia M, Cammisa M, Suster S, Colby TV. Erdheim-Chester disease: clinical and pathologic spectrum of four cases from the Arkadi M. Rywlin slide seminars. Adv Anat Pathol. 2003;10:160–171
  28. Andrade VP, Nemer CCV, Prezotti ANL, Goulart WSL. Erdheim-Chester disease of the breast associated with Langerhans-cell histiocytosis of the hard palate. Virchows Arch. 2004;445:405–409
  29. Furmanczyk PS, Bruckner JD, Gillespy T, Rubin BP. An unusual case of Erdheim-Chester disease with features of Langerhans cell histiocytosis. Skeletal Radiol. 2007;36:885–889
  30. Kerzl R, Eyerich K, Eberlein B, Hein R, Weichenmeier I, Behrendt H, et al. Parallel occurrence of Erdheim-Chester disease and eosinophilic granuloma in the same patient. J Eur Acad Dermatol Venereol. 2009;23:224–226
  31. Adle-Biassette H, Chetritt J, Bergemer-Fouquet AM, Wechsler J, Mussini JM, Gray F. Pathology of the central nervous system in Chester-Erdheim disease: report of three cases. J Neuropathol Exp Neurol. 1997;56:1207–1216
  32. Vital C, Bioulac-Sage P, Tison F, Rivel J, Begueret H, Gomez C, et al. Brain stem infiltration by mixed Langerhans cell histiocytosis and Chester-Erdheim disease: more than just an isolated case?. Clin Exp Pathol. 1999;47:71–76
  33. Annels NE, Da Costa CE, Prins FA, Willemze A, Hogendoorn PC, Egeler RM. Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis. J Exp Med. 2003;197:1385–1390
  34. Stoppacciaro A, Ferrarini M, Salmaggi C, Colarossi C, Praderio L, Tresoldi M, et al. Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis. Arthritis Rheum. 2006;54:4018–4022
  35. Mossetti G, Rendina D, Numis FG, Somma P, Postiglione L, Nunziata V. Biochemical markers of bone turnover, serum levels of interleukin-6/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. Clin Exp Rheumatol. 2003;21:232–236
  36. Reid CD, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol. 1992;149:2681–2688
  37. Vencio EF, Jenkins RB, Schiller JL, Huynh TV, Wenger DD, Inwards CY, et al. Clonal cytogenetic abnormalities in Erdheim-Chester disease. Am J Surg Pathol. 2007;31:319–321
  38. Braiteh F, Boxrud C, Esmaeli B, Kurzrock R. Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. Blood. 2005;106:2992–2994

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)00996-7

doi: 10.1016/j.jaad.2009.08.013

Journal of the American Academy of Dermatology
Volume 63, Issue 2 , Pages 284-291 , August 2010